Codes / ICD10CM / T38.0X5D

T38.0X5D Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter

Summary

This condition describes a patient experiencing negative side effects or adverse reactions to glucocorticoids or their synthetic analogues during a subsequent encounter for the same issue. Glucocorticoids are commonly used for their anti-inflammatory and immunosuppressive properties, and this code applies when the adverse effect is being managed in a follow-up visit.

Causes

The adverse effects are typically caused by the continued use of glucocorticoids, either through prescription medication for conditions such as arthritis, asthma, or autoimmune diseases, or through misuse or overuse of these substances. The subsequent encounter indicates ongoing management of the reaction.

Risk Factors

  • Prolonged use of glucocorticoids
  • Dosage higher than recommended
  • Sensitivity or allergic response to the medication
  • Use in conjunction with other medications that may exacerbate side effects

Symptoms

Potential symptoms include insomnia, high blood pressure, increased appetite, mood changes, or more severe effects like Cushing's syndrome, osteoporosis, or hyperglycemia. The specific symptoms depend on the type and duration of glucocorticoid exposure.

Diagnosis

Diagnosis typically involves a detailed assessment of the patient’s medication history, physical examination, and may include blood tests to check for metabolic disturbances related to medication use. The subsequent encounter context confirms prior documentation of the adverse effect.

Treatment Options

  • Discontinuation or reduction of the glucocorticoid dosage under medical supervision.
  • Replacement with alternative medications if necessary.
  • Management of specific symptoms (e.g., antihypertensives for high blood pressure).
  • Monitoring for resolution or progression of the adverse effect.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect and the patient’s response to treatment. Follow-up care is essential to monitor for symptom resolution, adjust therapy, and prevent recurrence. Regular assessments may be needed to evaluate long-term effects like osteoporosis or metabolic changes.

Complications

  • Development of Cushing's syndrome with prolonged exposure.
  • Osteoporosis or increased fracture risk.
  • Hyperglycemia or diabetes mellitus.
  • Adrenal suppression requiring gradual tapering of medication.

Lifestyle & Prevention

  • Adhere to prescribed dosages and schedules.
  • Report new or worsening symptoms promptly.
  • Maintain a balanced diet and regular exercise to support bone health.
  • Avoid self-adjusting medication without medical guidance.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe symptoms such as extreme fatigue, uncontrolled blood pressure, or signs of infection. Contact a healthcare provider for persistent or worsening side effects during follow-up.

Tips for Medical Coders

Document the specific glucocorticoid or synthetic analogue involved, the nature of the adverse effect, and the details of the subsequent encounter (e.g., follow-up visit, ongoing management). Ensure the encounter is clearly linked to the prior adverse effect to justify the use of this code.

Book a walkthrough

T38.0X5D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.